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Abstract: 
Introduction 
In order to achieve the virtual elimination of mother-to-child transmission of HIV (MTCT) in 
South Africa, novel approaches to improving prevention of mother-to-child transmission 
(PMTCT) programme outcomes are needed. One such approach which has been promoted in 
other settings is male partner involvement (MPI), and there is some evidence that MPI has a 
positive effect on pregnant HIV-infected women’s adherence to antiretroviral (ARV) 
regimens. In South Africa, however, little is known regarding the extent and effect of MPI. 
This study aimed to investigate disclosure, adherence, and MPI during pregnancy, with a 
view to exploring the associations between these variables as well as the feasibility of MPI.  
 
Methods 
A quantitative survey (n=170) and two focus group discussions (FGDs, n=7 and n=9 
respectively) were conducted in a public sector antenatal service in Khayelitsha, South 
Africa, in 2013. Pregnant HIV-infected women attending an antenatal visit were approached 
to participate. Two multiple logistic regression models were built in order to investigate the 
predictors of disclosure and MPI respectively. FGDs were analysed using thematic analysis.  
 
Results 
Of the 170 survey participants, 74% had disclosed their status to their partner. In multivariate 
analysis, disclosure was significantly more likely among participants who knew their 
partner’s status (AOR: 8.8; 95% CI: 3.1-25.1); and those who reported higher levels of HIV-
related discussion with their partner (AOR: 18.2; 95% CI: 6.6-50.1). The FGD participants 
emphasised barriers to disclosure, with the primary barrier being that of fear, but also 
discussed the necessity of disclosing. 
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All of the survey participants were taking ARVs, and 79% reported that they had not missed 
a dose during pregnancy. Adherence was significantly higher among older participants 
(p=0.008). Most participants received adherence support from their partners.  
 
The survey participants reported high rates of MPI, with most indicating that their partners 
provided financial support for their antenatal visits (85%); knew when their antenatal visits 
were (95%); discussed with them what happens during the visits (96%); and had discussed 
with them ways to prevent MTCT (89%). Fewer participants reported that their partners 
accompany them to antenatal visits (35%). In multivariate analysis, high involvement was 
significantly more likely among participants who were cohabiting with their partners (AOR: 
7; 95% CI: 2.0-24.0) and those who reported higher levels of HIV-related discussion with 
their partner (AOR: 13.2; 95% CI: 3.8-45.4).  
 
Participants in the FGDs discussed ways in which partners can be supportive during 
pregnancy, but acknowledged that some partners are not supportive, and that support, when 
provided, is often limited to pregnancy. Participants discussed their desire for their partners to 
accompany them to antenatal visits, but acknowledged health facility barriers to this. 
 
Conclusion 
Rates of MPI are fairly high in this population, and MPI appears to be feasible in this context, 
suggesting the potential to include MPI interventions within PMTCT programmes. However, 
interventions should aim to increase involvement in a variety of activities, and should not 
focus on antenatal attendance alone. Opportunities to facilitate communication within couples 
are needed, and interventions need to be appropriate to the nature of these relationships. 
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Introduction: 
Background and justification: 
The South African National Department of Health and the South African National AIDS 
Council presented their revised clinical guidelines for the prevention of mother-to-child 
transmission (PMTCT) of HIV in 2010. These guidelines are in line with international 
recommendations for the care of mothers and their infants in the context of HIV, and include 
recommendations for antiretroviral therapy during delivery as well as for both antenatal and 
postnatal care [1]. PMTCT programmes which are based on these guidelines can significantly 
reduce the risk of transmission of HIV from an infected mother to her child [2].  
 
However, it is argued that despite the implementation of PMTCT programmes, as well as the 
recent increase in the coverage of the programmes nationally [3], mother-to-child 
transmission of HIV (MTCT) in South Africa is still high in terms of the country’s goals [4]. 
Globally, the aim is to reduce the incidence of HIV infection in children by 90% by 2015 [5], 
and the aim in South Africa is to reduce MTCT to less than 2% at 6 weeks of age and less 
than 5% at 18 months of age [3]. The aim in South Africa is to achieve these reductions by 
2016, and the country thus still has a way to go, as MTCT at 6 weeks of age was 3.6% in 
2010 [4]. It is thus necessary to investigate novel approaches to improving PMTCT 
programme outcomes.   
 
Questions have been raised regarding the impact of male partner involvement (MPI) in the 
context of PMTCT. It is argued that although it has been acknowledged that MPI is 
important, little is known about the extent of involvement and about the affect which it has 
[2]. One of the aims of the South African guidelines for PMTCT is to involve women’s 
partners and families in PMTCT services in order to ensure a comprehensive approach [1], 
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however, the guidelines do not put forward comprehensive recommendations as to how to 
achieve this.  
 
Both the National Strategic Plan on HIV, STIs and TB and the National Action Framework 
for ‘No Child Born with HIV by 2015 & Improving the Health and Wellbeing of Mothers, 
Partners and Babies in South Africa’ highlight the need to strengthen PMTCT programmes 
by involving and engaging with men, for example by increasing their participation in PMTCT 
services and antenatal clinics [3, 4]. These echo the UNAIDS Global Plan, which also argues 
that a comprehensive prevention and treatment approach must include the support and 
involvement of men in PMTCT programmes [5]. However, as stated above, comprehensive 
recommendations have not yet been put forward as to how to achieve this, as little is 
currently known about the state of MPI in the context of PMTCT, as well as what is feasible 
in terms of this involvement in South Africa. 
 
For example, it has been argued that antenatal clinics in South Africa have been constructed 
as a female domain in which male attendance has traditionally been discouraged for cultural 
and health service delivery reasons, which has resulted in reproductive health services 
becoming inaccessible for men [6]. These issues thus need to be explored if MPI in antenatal 
care is to be encouraged. In addition, couple counselling and testing has been put forward as 
an important strategy in South Africa [3, 6]. As with MPI, however, little is known about the 
feasibility of this recommendation.  
 
Although rigorous PMTCT guidelines have been put forward, studies have shown that 
adherence to these guidelines is suboptimal in terms of adherence to antiretroviral (ARV) 
regimens in South Africa. For example, a recent study conducted in Mpumalanga found that 
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61% of pregnant women and 85.9% of postpartum women reported complete adherence to 
AZT in the four days before they were interviewed or in the four days before delivery, and 
that only 26% of antenatal women had never missed a dose of AZT during their pregnancy 
[7]. Lack of MPI was identified in this study as one of the factors which may negatively 
affect adherence [7].  
 
However, studies which address MPI define ‘involvement’ in different ways. For example, a 
study conducted in KwaZulu-Natal included proposed activities such as male partners 
accompanying women to the clinic during pregnancy and postpartum, and being present 
during labour and delivery, and found various degrees of willingness to be involved in each 
activity [6]. A study conducted in Uganda similarly included the activity of attending 
antenatal care as being indicative of MPI, but also included activities such as partners 
discussing antenatal PMTCT interventions and men providing financial support for antenatal 
visits in order to assess MPI [8]. In addition, a study conducted in Kenya included couple 
counselling and testing as a form of MPI [9].   
 
It is thus clear that MPI can refer to a range of activities within the context of pregnancy, and 
has not been clearly defined. In addition, it is argued that fatherhood within the context of 
HIV has not been adequately studied, particularly in terms of the role that fathers play [10]. 
Given the constantly changing roles of parents in South Africa [11], and particularly the 
added burden of parenthood in the context of HIV, more research is needed regarding the 
male role in the context of PMTCT and subsequent fatherhood. This research is particularly 
needed because of the positive impact which MPI appears to have on adherence to the 
guidelines for PMTCT [7, 12].  
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Although MPI appears to play an important role in women’s adherence to PMTCT 
guidelines, male partners must first have been informed of their partners’ HIV status in order 
for them to be involved in activities related to PMTCT. Studies conducted in various 
countries throughout Africa have found that the rate of women’s disclosure of their HIV 
status to their partners is low, and a study conducted in Pretoria found that only 48% of HIV-
positive pregnant women with partners had disclosed their status to their partners, and that 
this increased to 67% at follow-up three months postpartum, although there was loss to 
follow-up in the study [13]. Although various studies have explored the predictors of and 
barriers to disclosure in various countries throughout Africa, there has not been much 
exploration in South Africa of these factors and of issues such as the timing of disclosure and 
the differences between disclosing to a male partner compared to another family member or 
friend [13]. There is thus a need for research into these issues in South Africa.  
 
It is evident from the discussion above that there are several factors which are involved in 
women’s adherence to the guidelines for PMTCT, including MPI in PMTCT, the male role in 
the context of PMTCT, and women’s disclosure of their HIV status. However, these factors 
have not been adequately researched in South Africa, even though it has been acknowledged 
that they are important in increasing adherence to the PMTCT guidelines and thus in reducing 
the risk of the vertical transmission of HIV. The proposed study seeks to address these gaps 
in the literature by exploring these issues in the Western Cape.   
 
Aim: 
This formative research aims to explore the concept of MPI in the context of PMTCT from 
the perspective of pregnant women in order to generate a broader understanding of women’s 
experiences of MPI. Specifically, this study aims to explore disclosure, adherence, and MPI 
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during pregnancy, with a view to examining the associations between these variables as well 
as exploring the predictors of each. Currently, the antenatal guidelines for PMTCT are that 
pregnant women adhere to either a dual regimen of short-course PMTCT prophylaxis, which 
includes AZT and a single dose of Nevirapine, or continue with their triple regimen of 
lifelong ART, depending on their clinical stage of HIV, as defined by WHO, and their CD4 
count [1]
1
. In addition, the proposed study aims to explore issues surrounding HIV testing 
and the feasibility of couple counselling and testing. 
 
Objectives:  
The objectives of the proposed study are as follows: 
 To explore the rate of pregnant women’s disclosure of their HIV status to their male 
partners, as well as the predictors of disclosure. 
 To explore the extent and predictors of women’s adherence to ARVs during 
pregnancy. 
 To explore the concept of pregnant women’s perspectives of MPI during pregnancy in 
terms of men’s current involvement, as well as women’s desires for their 
involvement, in order to provide insight into the male role in the context of PMTCT. 
 To explore the predictors of MPI in the context of PMTCT. 
 To provide insight into the feasibility of MPI and couple counselling and testing in the 
context of PMTCT.    
 
 
                                                             
1 Subsequent to the drafting of this protocol in 2012, updated PMTCT guidelines adopting the “Option B” 
approach were released and implemented by the National Department of Health (2013). Fixed-dose combination 
ARVs were rolled out in South Africa, with pregnant women being among the first group of patients to be 
initiated on this regimen at the time of data collection in 2013 [National Department of Health. Changes in the 
antiretroviral therapy regimen in South Africa: fact sheet for civil society and the PLHIV sector. Pretoria: 
National Department of Health; 2013.] 
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A schematic representation of these objectives is as follows: 
 
 
 
Methods: 
Research design: 
The proposed study is a mixed methods study, as both quantitative and qualitative methods 
will be used in order to collect data.  
 
The quantitative component will involve conducting a survey in order to collect data 
regarding issues such as women’s disclosure of their HIV status and the predictors and 
barriers associated with this disclosure, MPI in the context of PMTCT, as well as adherence 
to ARVs. The quantitative nature of this component will enable an investigation of these 
different issues on a wide scale, and will enable a statistical investigation of the associations 
between the different variables. 
 
 
DISCLOSURE MALE PARTNER 
INVOLVEMENT IN 
PMTCT 
ADHERENCE 
Rate of 
disclosure 
Predictors of 
disclosure 
Women’s 
perceptions of 
men’s current 
involvement 
Women’s desires 
for male partner 
involvement 
Male role in the 
context of PMTCT  
Feasibility of male 
partner involvement 
in PMTCT 
Feasibility of couple 
counselling and 
testing 
Predictors of 
adherence 
Predictors of 
male partner 
involvement 
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Before collecting data, the questionnaire which will be used for the quantitative component of 
the proposed study will be piloted in order to ensure that it will generate the data needed, as 
well as to identify any problems with the data collection method or with the questions 
themselves. The piloting stage will thus be used in order to refine the questionnaire and 
address any problems regarding the data collection method before conducting quantitative 
data collection.  
 
The qualitative component will involve conducting focus group discussions (FGDs) in order 
to generate a more in-depth exploration of the issues of decision-making in the context of 
PMTCT, the male role in pregnancy, issues surrounding HIV testing, as well as the feasibility 
of MPI in PMTCT and of couple counselling and testing. FGDs, as opposed to individual 
interviews, were chosen as it is believed that they will give rise to richer data as a result of the 
content arising from group processes and discussions.   
 
Study site, population, and sampling:   
The study population for the proposed study comprises of HIV-positive pregnant women who 
are attending one public sector primary-level antenatal service in Khayelitsha, South Africa. 
From this site, HIV-positive pregnant women will be recruited to participate in the study. 
Because of the sensitive nature of HIV-infection, a convenience sample will be recruited. The 
assistance of nurses or other health care providers will be sought in order to identify eligible 
participants for the quantitative component of the study. These eligible participants will then 
be invited to participate in the study. For the qualitative component of the study, the 
assistance of support groups for HIV-positive pregnant women, namely mothers2mothers, 
will be sought in order to identify eligible participants. Again, these eligible participants will 
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then be invited to participate in the study. For both components of the study, women will be 
eligible to participate if they are HIV-positive, are pregnant, and have a male partner.  
 
For the quantitative component of the proposed study, a sample size calculation could not be 
performed because of the lack of an estimate of the proportion of antenatal PMTCT 
adherence in Cape Town. Taking into account the exploratory nature of this study, the sample 
size will thus be set at between 150 and 200 women, taking into account feasibility stemming 
from the proposed study. The final sample size for the survey will be constrained by the time 
and cost needed to recruit participants, as the proposed study is of a formative nature. In order 
to pilot the questionnaire before conducting data collection for the quantitative component of 
the study, a sample of 10 women will be selected.  
 
For the qualitative component of the proposed study, two FGDs will be conducted, with each 
FGD consisting of 6-12 women. Participants for the FGDs will be recruited at the antenatal 
service from the same population as those recruited for the quantitative component of the 
study.  
 
Data collection:  
As stated above, a survey will be conducted in order to collect data for the quantitative 
component of the proposed study. This survey will be an interviewer-administered 
questionnaire, in order to minimise any bias which may result from participants not fully 
understanding what is being asked of them.  
 
The questionnaire, which has been composed specifically for the proposed study, is 
composed of questions related to variables and factors which, according to the literature, are 
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important in the issues which the study aims to explore. The questionnaire will begin by 
asking socio-demographic questions in order to provide information about the sample and to 
provide information on variables which may be predictors of disclosure or adherence. In 
order to explore the predictors of and barriers to disclosure, questions will be asked regarding 
variables such as socioeconomic status and the nature of women’s relationships with their 
male partners, both of which have been found to be predictors of disclosure [13]. Questions 
will be asked regarding women’s disclosure of their HIV status to their male partners as well 
as to other significant people in their lives. These questions will address issues such as the 
timing of disclosure, as well as the reasons for disclosing or for not disclosing. In addition, 
questions regarding whether or not women know their male partners’ HIV status and whether 
or not they have discussed with their partners ways to prevent HIV transmission will be asked 
in order to explore issues regarding gendered power relations and the nature of women’s 
relationships with their male partners. 
 
Questions based on the NIAID AIDS Clinical Trials Group Adherence Interview [14], which 
aims to assess adherence to ARV regimens, will be asked. However, these questions will be 
simplified by asking women about their adherence to combined doses of ARVs rather than to 
each ARV drug individually. This simplification is deemed necessary, given the possibility of 
difficulties with recall and the fact that pill counts in order to assess the validity of self-
reported adherence will not be feasible given the nature of this study. Although the questions 
regarding adherence will be based on self-report, the questions have been validated in clinical 
trial settings, and should thus elicit valid information regarding ARV adherence. In order to 
further ensure that this information is valid, questions will be included to cross-check the 
consistency of responses regarding adherence. Questions will also be asked regarding the 
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reasons for adherence or non-adherence, as well as the difficulties encountered in attempting 
to adhere to these regimens. 
 
Finally, questions will be asked which will provide insight into the male role and MPI in the 
context of pregnancy and PMTCT. These questions will be based on how MPI has been 
operationalised in previous studies [6, 8]. The questions will focus on current MPI, what 
women would like in terms of MPI, and what their communities deem as being normative in 
terms of MPI.  
 
Throughout the questionnaire, a combination of both forced-choice and open-ended questions 
will be used. Open-ended questions will be included because of the complexity of the issues 
which will be explored, as not all possibilities may be covered by forced-choice questions, 
and it is important that the participants’ views and experiences are not constrained by this. As 
mentioned above, an interviewer will administer the questionnaire in order to minimise any 
bias which stems from participants not understanding what is being asked. The interviewer 
will be trained beforehand in the administration of the questionnaire, and it will be ensured 
that he/she is fluent in isiXhosa, the predominant language spoken in Khayelitsha. The 
questionnaire will be administered in either English or isiXhosa, according to each 
participant’s choice. In addition, as mentioned above, the questionnaire will be piloted in 
order to identify any problems regarding the data collection method or the questions 
themselves, and will then be refined before data collection is conducted.  
 
The qualitative component of the proposed study will make use of two FGDs, each of which 
will be approximately 1 – 1½ hours in duration, where the participants will be pregnant 
women from the same population as the women in the quantitative component. The FGDs 
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will be conducted in isiXhosa, the local language of the participants, and will be subsequently 
transcribed and then translated into English in order to be analysed. The discussions will thus 
be facilitated by an experienced research assistant who is fluent in isiXhosa. The researcher 
will, however, be present during both components of data collection in order to address any 
concerns which may arise during the process of data collection. 
 
The focus of the FGDs will be the objectives of the proposed study which are better suited to 
qualitative methods. A semi-structured interview guide will be used for this purpose, and will 
involve an exploration of issues pertaining to decision-making in the context of pregnancy 
and PMTCT, factors surrounding HIV testing and disclosure, the feasibility of couple 
counselling and testing for HIV, as well as a broader exploration of MPI in the context of 
pregnancy and PMTCT. The focus throughout this exploration will thus be on issues such as 
the nature of women’s relationships with their male partners, gendered power relations within 
these relationships, and gender roles and norms.  
 
It is believed that using FGDs will allow a more in-depth exploration of these issues than will 
be possible using the quantitative survey. However, it is also believed that the two 
components of the proposed study will be complementary and will generate rich data, both 
quantitative and qualitative, pertaining to issues about which little is known in South Africa.  
 
Data management: 
A database will be created using the data generated by the quantitative component of the 
proposed study. The data will be captured and quality assurance will be performed by 
checking a random 10% of the questionnaires for data capturing errors. As stated above, the 
qualitative FGDs will be transcribed verbatim and will then be translated into English before 
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being coded and analysed. Both the database and the transcriptions will be securely stored, 
and access to both will be based on the need of those involved in the research in order to 
ensure confidentiality.  
 
Data analysis:  
In order to analyse the data generated by the quantitative component of the proposed study, 
both univariate and multivariate analyses will be conducted using STATA version 12 
(StataCorp Inc, College Station, Texas, USA). This will be done in order to explore the 
concepts of disclosure, adherence, and MPI individually, as well as to explore the predictors 
of these outcome variables. As all three factors are operationalised as categorical outcome 
variables for the purpose of the proposed study, chi-squared tests will be used for the purpose 
of exploring the associations between these variables and the various predictor variables. In 
addition, regression analysis will be used in order to explore the variables which best predict 
these factors. The selection of predictor variables for the regression analyses will be based 
either on the significance of the variables as found during bivariate data analysis, or on their 
importance in predicting these outcomes as identified in the literature.  
 
In order to analyse the data generated by the qualitative component of the proposed study, 
thematic analysis will be conducted using the transcriptions of the FGDs. The discussions 
will be analysed according to the broad topics stemming from the interview guide as well as 
according to the repeated themes which emerge during the course of the thematic analysis. A 
coding scheme will be developed according to the repeated themes which emerge, and this 
scheme will be used for further coding, while being modified according to new themes which 
may emerge, until a point of saturation is reached [15]. Qualitative data analysis will thus 
follow a process that is both inductive and deductive, as it will involve a process of 
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continually refining the coding scheme and analysing the data according to this scheme in 
order to develop themes relating to each of the topics discussed during the FGDs. 
 
Although the two components of the proposed study will be analysed separately, these 
analyses will then be interpreted simultaneously, as it is believed that the two components 
will provide data which is complementary. The quantitative data will thus be used in order to 
generate an estimate of the extent and predictors of disclosure, adherence, and MPI in the 
study population, while the qualitative data will be used in order to generate a more in-depth 
understanding of these concepts. As little is known about the extent of and issues surrounding 
these factors in South Africa, these complementary approaches and outcomes are needed.  
 
Ethical issues: 
Ethical approval for the proposed study will be obtained from the Faculty of Health Sciences 
Human Research Ethics Committee. Once this approval has been obtained, provincial 
approval for the study will be obtained from the Western Cape Department of Health in order 
to conduct the study in the proposed antenatal service in Khayelitsha.  
 
The ethical principles which will be adhered to at all times during the proposed study will be 
those stated in the Declaration of Helsinki, which was developed by the World Medical 
Association for medical research involving human participants [16]. It will thus be ensured 
that the well-being of each individual participant takes precedence over all other interests 
[16]. In addition, the proposed study will be guided by the ethical principles and guidelines 
set out in the Belmont Report, namely those of respect for persons, beneficence, and justice 
[17]. 
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Many of the potential ethical issues which will need to be addressed while conducting the 
study are related to minimising participant distress, thereby minimising any harm to 
participants. When selecting participants for the study, the assistance of nurses or other health 
care providers will be sought, as mentioned above. Eligible participants will be approached 
discreetly after being identified, so as not to reveal their HIV status. Eligible participants will 
be given an information sheet, available in both isiXhosa and English, explaining the purpose 
and nature of the study and containing contact details of the researchers, and after it has been 
ascertained that the information is clearly understood, eligible participants will be invited to 
participate in the study. It will be made clear that participation is voluntary and that the study 
is not being conducted by the antenatal service, and thus that the decision of whether or not to 
participate in the study will not impact on the women’s antenatal treatment in any way. After 
it has been explained that participation is voluntary and that participants are free to withdraw 
from the study at any time, participants will be required to sign an informed consent form, 
again available in both isiXhosa and English. Separate information sheets and informed 
consent forms will be used for the two different components of the study.  
 
During quantitative data collection, the questionnaire will be administered by an experienced 
interviewer who is sensitive to the context of the study and who has received training, both in 
HIV information and counselling skills and in terms of the specific questionnaire which will 
be used for the study. The questionnaire will be administered to participants in either 
isiXhosa or English, according to their choice, and this will take place in a private room 
located within the antenatal service, at the participants’ convenience. Participants will not be 
required to provide their names and will be identified in the data using only numbers in order 
to ensure anonymity and confidentiality.  
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At the beginning of each FGD, the importance of confidentiality will be discussed with the 
participants. An experienced assistant who is similarly sensitive to the context of the study 
will facilitate the discussions in isiXhosa. When transcribing the FGDs, participants will be 
referred to using pseudonyms in order to maintain anonymity and confidentiality. Data from 
both components of the study will be securely stored, and access to the data will be based on 
the need of those involved in the research.  
 
Although individuals will not receive any benefits from participating in the proposed study, it 
will be ensured that justice arises from the study by timeously disseminating the results of the 
study to stakeholders such as local authorities in order to inform health policies regarding 
PMTCT. It is thus hoped that the results of the proposed study will lead to improved services 
for PMTCT in this community. This will be explained to all eligible participants.  
 
Budget: 
Budget for Proposed Study 
Item Cost per unit Number of units Total cost 
Field worker R60/hour 140 hours R8400 
Translation services R60/hour 4 hours R240 
Transcription 
services 
R60/hour 25 hours R1500 
Mileage R3.16/km 35 visits to study 
sites (approximately 
40km/visit) 
R4424 
Photocopying R0.30/page 1000 pages R300 
Refreshments for 
participants 
  R800 
Total   R15664 
 
Funding for the proposed study is available in the form of a University of Cape Town 
Research Development Grant.  
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Time frame: 
Time Frame for Proposed Study 
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Departmental and 
ethical approval 
              
Department of 
Health approval 
              
Site preparation, 
training, and set 
up of study 
              
Pilot study               
Data collection - 
quantitative 
              
Data capturing - 
quantitative 
              
Data analysis - 
quantitative 
              
Data collection - 
qualitative 
              
Data analysis - 
qualitative 
              
Writing of 
manuscript 
              
Submission of 
dissertation, 
dissemination of 
findings 
              
 
Dissemination of research findings: 
The research findings generated by the proposed study will be submitted in partial fulfilment 
of the requirements for the Master of Public Health (Epidemiology) degree at the University 
of Cape Town. The findings will be written as a potentially publishable article for an 
appropriate peer reviewed journal. In addition, the findings will be reported to various 
stakeholders such as local authorities. A copy of the report will be distributed to the 
management of the antenatal service involved in the proposed study, and an offer of a 
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presentation based on the results of the proposed study will be made to all interested 
stakeholders.  
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Objectives of literature review: 
1. To present the literature regarding disclosure to male partners and male partner 
involvement (MPI), as well as their effect on adherence to the antenatal guidelines for 
preventing mother-to-child transmission (PMTCT) of HIV. 
2. To describe reported barriers to and facilitators of disclosure to male partners and 
MPI. 
3. To discuss the literature regarding the feasibility of MPI.  
 
Literature search strategy: 
An initial search of the PubMed and PsycINFO databases was conducted. The Google 
Scholar search engine was also used for this purpose. The terms used in the initial search 
included “male partner involvement AND PMTCT”, “disclosure AND PMTCT”, and “male 
partner involvement AND adherence”. The reference lists of the literature found during the 
initial search were used to obtain further relevant literature. In addition, reports on MPI, key 
research in this field, and reviews of MPI were included, and the reference lists of these 
papers were used to obtain further relevant literature.    
 
Summary of the literature: 
Male partner involvement as a priority intervention: 
Programmes for the prevention of mother-to-child transmission (PMTCT) of HIV have been 
successfully implemented in many countries, including South Africa, however, challenges 
remain [1]. The prevalence of HIV among pregnant women in South Africa remains high [2], 
and although there has been progress in reducing mother-to-child transmission (MTCT), rates 
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of MTCT are still high in terms of the country’s goals [3]. Novel approaches to strengthen 
PMTCT programmes and subsequently reduce MTCT should thus be explored. Male partner 
involvement (MPI) in antenatal care has been put forward as one such approach.  
 
Although MPI has been the focus of much recent research, there is a lack of consensus about 
its definition [4] and about what activities constitute ‘involvement’ [5]. Some researchers 
have assessed MPI using a range of activities [6], but the majority of research has focussed 
narrowly on male attendance at antenatal clinics and male HIV testing [7]. Regardless of this 
lack of consensus, however, studies suggest that MPI is beneficial in terms of infant 
outcomes. Numerous studies have shown a strong inverse relationship between MPI and risk 
of MTCT in exposed infants [8]. For example, an early study (1999-2002) in Kenya found 
that male partner attendance at antenatal services and previous male testing led to a decreased 
risk of MTCT [9]. Increasing MPI has thus been highlighted as a priority within PMTCT 
programmes, which are currently largely women-centred [10].  
 
In addition, MPI may improve adherence to PMTCT guidelines, as both HIV-status 
disclosure and MPI appear to be facilitators of adherence. For example, in a study conducted 
in Tanzania it was found that disclosure was positively associated with AZT adherence 
during pregnancy [11]. Disclosure was similarly found to be significantly associated with 
adherence during pregnancy in a study conducted in Nigeria [12]. In a study of HIV-positive 
pregnant and postpartum women in Mpumalanga, disclosure was again found to be positively 
associated with adherence during pregnancy, and MPI was found to be positively associated 
with nevirapine adherence during labour and infant nevirapine adherence postpartum [13].  
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Although it has been recognised as beneficial, however, the extent of MPI remains low, and 
attempts to increase male partner attendance of antenatal care have been largely unsuccessful. 
The South African PMTCT guidelines include the promotion of MPI [14, 15]. MPI is also 
part of the PMTCT national policy in Tanzania, but this has not translated into actual male 
participation [16]. Early studies conducted in Tanzania (2002-2004) and Kenya (2001-2002) 
reported that the proportion of male partners presenting at antenatal clinics was only 12.5% 
[16] and 16% [17] respectively. Similarly, multiple strategies to encourage MPI have been 
implemented in Cameroon, but these have led to only limited success, with MPI not 
exceeding 20% [18]. 
 
Disclosure to male partners: 
In order for male partners to become involved in PMTCT with their pregnant partners, they 
must first have been informed of their partner’s HIV status. Disclosure is thus a prerequisite 
for MPI, and non-disclosure may be a significant barrier to MPI. An early review of 
disclosure reported fear as the most common barrier to disclosure, namely fear of 
abandonment, rejection, violence, and upsetting family members [19]. While many women 
desire support from their partners, others indicate that they do not want their partners to be 
involved in their antenatal care and PMTCT, for reasons which include prior experiences of 
violence from their partners as well as non-disclosure of their HIV status, often because they 
fear their partner’s reaction [7]. A study of HIV-positive pregnant women in Tanzania, for 
example, found a low rate of disclosure to male partners, with only 41% of participants 
having disclosed [20]. A low rate of disclosure (46.2%) has similarly been reported in Cote 
d’Ivoire [21]. 
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While the above studies reported fairly low rates of disclosure, vastly different rates have 
been found in different contexts. In a study conducted in Nigeria, for example, 91.3% of 
female participants had reportedly disclosed to their partner, with the major reason put 
forward being to ensure emotional and economic support [22]. In contrast, a study conducted 
in Tshwane, South Africa, found that only 59% of newly diagnosed HIV-positive pregnant 
women had disclosed their HIV status to at least one person at the time of interview, with the 
major reasons for partner disclosure being to inform partners of the risk of infection, and to 
encourage them to be tested and to change their risk behaviours [23]. Very few women 
reportedly disclosed in order to obtain support for PMTCT activities, and the major reasons 
put forward for non-disclosure were fear and not yet being ready to disclose [23]. 
 
Efforts to decrease MTCT have led to increasing numbers of women discovering that they are 
HIV-positive during pregnancy, which may be particularly traumatic as there is little time to 
deal with the diagnosis while simultaneously preparing for the birth of the child [23]. Women 
are likely to discover their HIV status before their partners, as a result of being routinely 
tested at antenatal services, and are then burdened with the responsibility of disclosing [24]. 
In addition, a large proportion of pregnancies in South Africa are unplanned, thus placing 
women in a ‘double disclosure bind’, where they are responsible for communicating both 
their HIV status and their unintended pregnancy to their partners, many of whom they are not 
in stable relationships with [24]. For example, 60% of participants in a study conducted in 
KwaZulu-Natal had experienced both an unintended pregnancy and a recent HIV-positive 
diagnosis [24]. Most participants were single and not cohabiting, and were fearful that 
disclosure would lead to abandonment [24]. It is thus unsurprising that these women 
prioritised maintaining their relationships and receiving continued support during an 
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unintended pregnancy over disclosing, and HIV counselling strategies thus need to take into 
account the personal and cultural contexts of disclosure [24].  
 
Other authors similarly suggest that women who are diagnosed during pregnancy have a 
relatively short period of time to deal with their diagnosis before the birth of their child, but 
that hiding their diagnosis may lead to a greater risk of MTCT if they are unable to adhere to 
their antiretroviral regimen correctly because they fear inadvertent disclosure [25]. Despite 
these concerns, however, a study conducted in Pretoria, Tshwane, found that 59% of female 
participants who were diagnosed during pregnancy had disclosed their diagnosis early, and 
that the majority (81%) had disclosed by three months postpartum [25]. Although the 
majority of women who disclose report supportive reactions from their partners [26], fears 
related to disclosure should nonetheless be taken into account during HIV counselling and 
testing, as they represent a major barrier to disclosure and subsequent MPI. 
 
Barriers to male partner involvement: 
Although the extent of MPI remains low, studies have found that both men and women in 
certain contexts desire greater MPI in antenatal care. For example, married men in Uganda 
reportedly wish to be included in antenatal and PMTCT services [27]. Women in Tanzania 
would reportedly like their partners to accompany them to antenatal visits, and men within 
the same context wish to play a more active role in their partner’s pregnancy [28]. It has been 
recognised, however, that although the majority of men hold positive attitudes towards 
PMTCT, the proportion of men who engage with PMTCT services and activities remains low 
[10, 29].  
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Given the fact that both men and women appear to desire greater MPI in antenatal care, but 
that MPI remains limited, much literature has focussed on the barriers to involvement. 
Barriers have been identified at various levels, ranging from individual to societal and 
structural factors. For example, in a study of barriers to MPI in Kenya, barriers such as 
difficulties in attending antenatal appointments because of work commitments, difficulties in 
communication within couples, a lack of understanding among men regarding the importance 
of participating in PMTCT programmes, HIV-related stigma, traditional cultural norms and 
gender roles, and the perceived negative attitudes of clinic staff were identified [30]. In a 
study conducted in Cameroon, it was similarly found that one of the major barriers to MPI is 
the time needed for men to attend antenatal visits [31]. It is thus argued that antenatal 
attendance may not be an appropriate indicator of MPI or male partner support [4]. 
 
Prevalent traditional gender roles are a major barrier to MPI, as these have created a culture 
whereby men are not actively involved in pregnancy. For example, a study conducted in 
Tanzania found that men do not recognise the importance of their attendance at antenatal 
visits, instead believing that antenatal care is a solely female responsibility [28]. Similarly, a 
study conducted in Khayelitsha, Cape Town, reported that men generally see no reason to 
attend antenatal visits [32]. Men in Cameroon who indicated that male attendance at antenatal 
visits is unnecessary similarly reported that pregnancy is a women’s affair, and that it is not 
customary for men to participate in antenatal care [31]. The majority of men surveyed 
indicated that financial support is adequate in terms of MPI [31]. A study conducted in 
Uganda in 2004 reported that while 97% of men interviewed provided financial support to 
their female partners, only 4.7% of the men had attended antenatal services with their 
partners [6]. 
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Traditional gender roles and social norms, and the common perception that antenatal care is a 
woman’s responsibility, have resulted in antenatal services in which men do not feel welcome 
or comfortable [33, 34]. The fundamentally female-oriented nature of PMTCT programmes 
thus act as a major deterrent for, and barrier to, men [33, 34]. The exclusive use of these 
services by women, due to health service delivery and cultural factors, has made them 
inaccessible for men [35]. It is argued that this can be explained by two structural and social 
norms, namely that reproductive health has become a solely female arena, and that the focus 
on maternal and child health and the emphasis on women’s rights and access to health care 
has contributed to a reproductive health care system from which men are largely excluded 
[28]. Persistent cultural beliefs about gender roles have thus been exacerbated by the health 
care system itself, and these broad social and societal influences deny men the opportunity to 
access these services with their partners. 
 
It is argued that the most significant obstacle to MPI is perhaps these conceptual and policy 
barriers that, through their institutionalisation of maternal health as a women-only realm, 
have led to men being excluded from PMTCT and other reproductive health services [29]. 
PMTCT programmes traditionally focus on women, because vertical transmission of HIV can 
only occur from a mother to her child, and the fact that reproduction is traditionally 
associated with women has led to a system of thinking in which sexual and reproductive 
health services are similarly associated with women, thereby unconsciously legitimating the 
exclusion of men and, by extension, couples [10]. 
   
The possible negative impact of health care providers has also been identified as a potential 
reason for limited MPI. Studies conducted in Uganda [6, 36] and in Khayelitsha, Cape Town, 
have found that men who accompany their partners to antenatal clinics are forced to wait 
35 
 
outside. A study conducted in Tanzania found that health care providers hold generally 
positive attitudes toward male attendance at antenatal services, but that these positive 
attitudes do not translate into actual male partner attendance [37]. Indeed, an earlier study 
conducted in the same region found that many men had been turned away by staff when 
attempting to attend these services with their partners [28]. In Zambia, midwives are trained 
to encourage MPI, but this does not necessarily lead to service environments which are 
conducive to male participation, and health care providers’ attitudes and services which are 
not male-friendly have also been identified as barriers to MPI in this context [38].  
 
In a review of the facilitators of and barriers to MPI, it was found that the most frequently 
reported barrier was the belief held by men that antenatal care is purely a women’s domain 
and responsibility [39]. This cultural barrier to MPI has been identified by numerous authors 
in many different contexts, and has been discussed extensively above. Hence, it appears as 
though this widespread belief in traditional gender roles may be the major obstacle in 
engaging men in antenatal care and PMTCT services, both from a supply and demand 
perspective.  
 
Other major barriers to MPI identified were those of time and men’s reluctance to learn their 
HIV status, as well as the belief that one’s partner’s HIV status is a proxy for one’s own [39]. 
The early study which reported that only 16% of male partners in Kenya attended antenatal 
services found that the major reason put forward by respondents for other men not attending 
the clinic was the fear of testing positive [17]. In a study of men whose female partners had 
recently been pregnant in Pretoria, Tshwane, it was reported that while the vast majority 
(94.4%) of participants believed that male HIV testing is important, only 59.7% had ever 
been tested, and only 46% had ever discussed HIV testing with their partners [40]. The men 
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in the study were more likely to have discussed HIV testing with their partners if they were 
married, and more likely to have been tested if they had previously discussed HIV testing 
[40]. The results of this study thus indicate that communication could enable and strengthen 
couple testing.  
 
A qualitative study in Pretoria found that while the majority of fathers who participated 
recognised the importance of HIV testing, barriers to HIV testing put forward included time, 
the fear of testing positive, and the lack of social expectations for men to get tested when 
their partners are pregnant. It is argued that HIV testing and the involvement of men at 
antenatal services is structurally inaccessible, as antenatal care programs have been designed 
to include the routine counselling and testing of women, at the expense of their male partners 
[34].  
 
A study in Tanzania found that while men support the routine testing of women in the context 
of antenatal care, they are very resistant to being tested themselves, evident in the fact that 
only 3% of partners were tested at the antenatal clinics included in the study, despite the 
women being encouraged to bring their partners for testing [33]. It thus appears as though 
PMTCT programmes are an accepted entry point into HIV care for women [41], but not for 
men. Women are seen within these services as a way to access men, and the responsibility for 
bringing partners to the clinic for testing lies with these women [33]. Given the barriers to 
male attendance at antenatal services, it appears as though other approaches need to be 
explored in order to access men.  
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The nature of relationships and their effect on male partner involvement: 
Finally, a male ‘partner’ can refer to various types of relationships. The nature and 
complexity of relationships between men and women has been identified as a barrier to MPI, 
as many couples may find themselves in less stable relationships where they are not married 
or cohabiting, and which may make MPI even less likely [39]. In a study of Ugandan fathers 
it was found that the nature of relationships between men and women is a major barrier to 
MPI, in this case to couple counselling and testing [36]. The authors reported that men 
described their marriages as unstable and distrustful, and explained their reluctance to attend 
couple counselling and testing by alluding to the conflict that it may lead to in their marriages 
[36]. These men were thus reluctant to attend antenatal services, as they were fearful of being 
tested [36].  
 
In a review of the determinants of MPI, it was found that factors associated with increased 
MPI included cohabiting with one’s partner, while barriers to MPI included poor 
communication within couples [8]. Cohabiting has also been found to be associated with 
disclosure [21], as has marriage [25], indicating the importance of the nature of relationships, 
as women who are in stable relationships appear to be more likely to disclose their HIV status 
and to receive support from their partners.  Another review similarly highlighted the 
importance of communication in improving MPI [42]. In the context of an intervention study 
in Mpumalanga, female participants discussed their feelings of helplessness to communicate 
with their partners [43]. These women perceived their partners as being uninvolved and 
uninterested in their antenatal care, while the men discussed their feelings of sadness and 
neglect after their partners had failed to involve them [43]. This again highlights the impact 
that the nature of relationships between men and women can have on MPI, as well as the 
need to increase communication within couples. 
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Unstable relationships appear to be the norm in South Africa, with the ‘typical’ child being 
raised by their mother in a single-parent household [44]. Another concerning trend is that the 
proportion of children who have absent, living fathers is increasing [44]. Taking into account 
the nature of relationships between men and women means acknowledging this reality, and 
then tailoring health services to fit these circumstances.  
 
While unstable relationships may lead to a lack of MPI, however, this may be perpetuated by 
women, who often do not inform their partners of antenatal care or PMTCT, or choose to not 
involve their partners in these activities, often from fear of their partner’s reaction [39]. A 
study conducted in 2011 in Cameroon reported that the majority of female participants 
believed that financial support is sufficient in terms of male support during pregnancy, and 
that most had never asked their partners to accompany them to antenatal visits, assuming that 
they would not want to do so [18]. This again highlights the deeply entrenched cultural norms 
which act as a barrier to MPI [18].  
 
The need for increased efforts to promote male partner involvement: 
Given all of these barriers to MPI, the question remains as to why certain men manage to 
overcome these barriers in order to support their pregnant partners and to be actively engaged 
in antenatal care. Why do some men, albeit few, overcome the health system constraints and 
challenge traditional gender norms, while others are content to simply provide financially for 
their partners? It is argued that it is likely that these men, who are not representative of all 
men, are already supportive and involved before the pregnancy [36]. Studies seem to support 
the argument that men who participate in PMTCT and antenatal services are men who are in 
committed relationships characterised by good communication [10, 29]. Interventions to 
address improved trust and communication include the MenCare campaign in South Africa, 
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which aims to promote MPI by encouraging fatherhood, along with encouraging partners to 
be active participants in maternal and child health [10]. 
 
While efforts to increase MPI have been largely unsuccessful, the argument can still be made 
for increasing these efforts. It is argued that one way to address the comprehensive needs of 
women is through family-centred models of PMTCT, one component of which is MPI [45]. 
While it is clear that MPI improves health outcomes in the context of PMTCT, this approach 
has yet to fulfil its promising potential [45]. Health services need to be reoriented to see men 
as clients who, along with their female partners, need to be prepared for parenting [35]. The 
focus of antenatal services should thus shift from being exclusively about pregnant women 
who have male partners, to being about couples who are experiencing pregnancy together, 
and should be treated and engaged as such. In order to eliminate MTCT, health services from 
which half of the population are excluded need to be restructured [10, 29].  
 
However, an exclusive focus on male partner attendance at antenatal clinics is clearly 
ineffective, and thus a broader focus is needed. Although MPI is frequently operationalised as 
attendance at antenatal clinics, male participants of a study in Durban, KwaZulu-Natal, 
reportedly provide a range of different types of support to their female partners, the main 
form of which is financial support, but which also includes men reminding their partners of 
when their PMTCT appointments are, and in some cases providing emotional support [7]. 
Time and space at services were again put forward as barriers to male partner attendance in 
this study [7]. Perhaps efforts to increase MPI thus need to additionally focus on other ways 
in which men can be involved in and engaged with their partner’s pregnancy [7]. 
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As argued above, there is a need to rethink ways of improving MPI, and better strategies are 
needed in order to increase MPI, as the traditional clinic-based approach does not appear to 
be particularly effective [16]. Interventions at the societal and structural level are needed in 
order to create a culture in which both men and women take part in and share the 
responsibility for reproductive care [27]. Finally, there is a need to move beyond the view of 
men as obstacles to health to a view of men as integral partners in promoting gender equality 
and health [10]. There is a need to move beyond the view of men as being ‘facilitating 
factors’ which enable women to access health care services. Rather, full engagement with 
men as part of the couple could promote communication within couples and normalise men’s 
involvement in PMTCT and antenatal services [29]. 
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Abstract: 
Male partner involvement (MPI) has been identified as a priority intervention in programmes 
for the prevention of mother-to-child transmission (PMTCT) of HIV. This study made use of 
a quantitative survey (n=170) and two focus group discussions (FGDs) in Khayelitsha, South 
Africa, in order to explore disclosure, adherence, and male partner involvement (MPI) during 
pregnancy. Seventy-four percent of the survey participants had disclosed their status to their 
partner, and the participants reported high rates of MPI. Higher reported levels of HIV-
related discussion with partners was significantly associated with both disclosure and high 
MPI. Most participants received adherence support from their partners. The FGD participants 
emphasised barriers to disclosure, but also discussed the necessity of disclosing, and 
discussed ways in which partners can be supportive during pregnancy. MPI interventions 
should aim to increase discussion within couples, as well as to increase male involvement in 
and support for a variety of pregnancy-related activities.
2
 
 
 
 
 
 
 
 
 
 
                                                             
2 Variations from journal requirements: For the purpose of dissertation submission, tables are inserted in the text 
of the manuscript rather than appended at the end of the manuscript. 
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Introduction: 
Much progress has been made in prevention of mother-to-child transmission (PMTCT) 
programmes in South Africa over the past decade, with a mother-to-child transmission 
(MTCT) rate of  2.7% reported at around 6 weeks of age [1]. Despite the successful 
implementation of PMTCT programmes, challenges remain in eliminating MTCT [2] and 
novel approaches to improving PMTCT programme outcomes are needed. Male partner 
involvement (MPI) has been put forward as a priority intervention to increase programme 
coverage and to promote a family-centred approach to HIV care [3, 4]. HIV-status disclosure 
to a male partner and MPI have been shown to significantly improve antiretroviral (ARV) 
adherence during pregnancy in South Africa [5], however, rates of MPI remain low 
worldwide [4].  
 
Little is known about the extent of disclosure and adherence and the role of MPI in the 
context of PMTCT in South Africa. Research in this regard is thought to be narrowly 
focussed on male attendance at antenatal clinics and male HIV testing [6]. A precise 
definition of ‘MPI’ is lacking [7], with poor consensus regarding the activities ‘involvement’ 
includes [8]. Male partner involvement could strengthen all four pillars of PMTCT, for 
example by increasing levels of HIV testing and counselling among men, and by involving 
men in family planning. The focus of this article, however, will be on male partner 
involvement in PMTCT during pregnancy. This formative research aimed to explore the 
concept of MPI from the perspective of pregnant women in order to generate a broader 
understanding of women’s experiences of MPI. Specifically this study explored disclosure, 
adherence, and MPI during pregnancy, with a view to examining the associations between 
these variables. 
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Methods: 
Participants and procedures: 
This study was conducted at an antenatal service in Khayelitsha, South Africa, between July 
and November, 2013. Khayelitsha has the highest antenatal HIV seroprevalence in the 
Western Cape (37% in 2011), and is an area characterised by high levels of unemployment 
(38%) and instability [9]. The study consisted of a quantitative survey and two qualitative 
focus group discussions (FGDs). Pregnant women were eligible to participate if they were 
HIV-positive and had a male partner. In the literature on MPI in PMTCT, most studies do not 
make explicit the definition of a ‘male partner’. Studies that do make this clear define a 
‘partner’ as a primary sexual partner, who may or may not be the father of the child [6, 10, 
11]. This study similarly defined ‘partner’ as a primary sexual partner, and participants were 
interviewed regarding their cohabitation and marital status in order to categorise different 
types of relationships.  
 
Given the exploratory nature of the study, a convenience sample was recruited for the survey 
(n=170) and the two FGDs (n=7 and n=9) respectively. Eligible participants for both 
components of the study were identified with the assistance of health care providers and 
support groups for HIV-positive pregnant women. All participants provided written informed 
consent prior to participation. The study was approved by the University of Cape Town’s 
Faculty of Health Sciences Human Research Ethics Committee and the local health authority.  
    
Data collection: 
A trained field worker conducted the interviews for the survey and FGDs in isiXhosa, the 
participants’ mother tongue. A paper-based questionnaire with closed and open questions was 
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developed and was piloted prior to data collection. Quantitative data collected included 
variables pertaining to the sociodemographic characteristics of the participants and their 
partners, the nature of the relationship between participants and their partners, HIV testing 
and HIV-status disclosure, antiretroviral therapy (ART) adherence, and the participants’ 
experiences of and desires for MPI during pregnancy.  
 
Disclosure to male partners was self-reported, resulting in a binary categorisation of 
disclosure and non-disclosure. Adherence was measured using questions based on the NIAID 
AIDS Clinical Trials Group Adherence Interview [12]. Levels of HIV-related discussion 
were assessed by asking each participant whether or not she had discussed HIV testing and 
the prevention of horizontal transmission with her partner. A discussion score was calculated 
by summing the number of topics the participant had discussed with her partner (maximum 
2). A score of 0-1 indicated low levels of discussion, and a score of 2 indicated high levels of 
discussion. 
 
Given that a standardised measure to assess MPI is lacking [13], involvement was assessed 
using a range of activities based on how MPI was operationalised in a study conducted in 
Uganda [14]. In this study, these activities were partner involvement in providing financial 
support for antenatal visits; knowing when antenatal visits were; discussing what happens 
during antenatal visits with their pregnant partner; discussing with their partner ways to 
prevent PMTCT; and accompanying their partner to antenatal visits. In order to compare 
levels of MPI, a scoring system was devised in which an MPI score was calculated by 
summing the number of reported activities the partner carried out (maximum 5). A score of 0-
3 indicated low involvement, and a score of 4-5 indicated high involvement.  
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Based on preliminary results of the survey, a FGD guide was developed to obtain similar, but 
more in-depth information. The FGDs were digitally recorded. MPI was not defined for the 
purposes of the FGDs, thereby allowing participants to put forward their own views of what 
activities constitute MPI.  
 
Data analysis: 
The survey data were analysed using bivariate analysis, in order to identify variables which 
were significantly associated with the outcomes disclosure, adherence, and MPI. The 
associations were deemed significant if χ2 or Fisher exact tests, in the case of categorical 
variables, or t-tests, in the case of continuous variables, led to a p-value of less than 0.05. 
Odds ratios (OR) with 95% confidence intervals (CI) were calculated in order to determine 
the strength of these associations.  
 
Two logistic regression models were then built, one in which the outcome was disclosure and 
the other in which the outcome was MPI. Variables were included in the logistic regression 
models if they had been significantly associated with each of the respective outcomes in 
bivariate analysis. Forward stepwise procedures were used for model building, adding each of 
the variables which were associated with the outcome in bivariate analysis individually. 
Likelihood ratio tests were used to assess model fit. Marital status was controlled for when 
building the model of disclosure, as this variable almost reached significance in multivariate 
analysis, and improved the model fit. Disclosure status was controlled for when building the 
model of MPI, as it was presumed that disclosure is a prerequisite for MPI in PMTCT. Data 
were analysed using Stata 12 (StataCorp Inc, College Station, Texas, USA). 
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The qualitative data from the FGDs were transcribed and translated into English. The 
transcriptions were checked by an independent source and back translated for quality 
assurance. The transcribed discussions were then analysed using thematic analysis, whereby 
they were coded according to the repeated themes which emerged, with the coding scheme 
being developed and modified as analysis progressed, until a point of saturation was reached 
[15].  
 
Results: 
Sociodemographic characteristics: 
One hundred and seventy HIV-positive pregnant women participated in the survey, while 16 
women from the same population participated in the FGDs. Detailed sociodemographic 
characteristics of these participants are presented in Table 1. The survey participants’ median 
age was 29 years (Interquartile Range [IQR]: 26-33). The majority of the participants had not 
completed secondary education (68%), and just over half were unemployed at the time of the 
interview (55%). Partners were on average older than the participants (Partner median age = 
33; IQR: 29-37), and had higher levels of education and employment. Most participants 
(83%) had previously been pregnant. Sixty-eight percent (n=115) of the current pregnancies 
were unplanned. Unplanned pregnancy was significantly more likely among unmarried 
participants (OR = 3.2; 95% CI: 1.5-7.0). Just over a quarter of participants were married 
(26%), and 52% of participants were cohabiting.  
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Table 1 Participant and partner characteristics 
Variable n (%) 
Survey participants  
Median age (Inter-quartile Range [IQR]) 29 (26-33) 
Race  
    Black/African 
 
170 (100) 
Language  
    English 
    isiXhosa 
    Sesotho 
 
1 (0.6) 
168 (98.8) 
1 (0.6) 
Education  
    Primary school 
    Some secondary education 
    Matric/tertiary education     
 
5 (2.9) 
110 (64.7) 
55 (32.4) 
Employment  
    Employed  
 
75 (44.1) 
Partners’ median age (IQR) 33 (29-37) 
Partner’s education  
    Primary school 
    Some secondary education 
    Matric/tertiary education 
    Unknown 
 
5 (2.9) 
60 (35.3) 
90 (52.9) 
15 (8.8) 
Partner’s employment  
    Employed 
 
142 (83.5) 
Marital status 
    Married    
 
44 (25.9) 
Cohabitation status 
    Cohabiting     
 
89 (52.4) 
Number of weeks pregnant at time of interview 
    Second trimester 
    Third trimester 
 
42 (24.7) 
128 (75.3) 
Gravidity 
    First pregnancy 
 
29 (17.1) 
Decision making regarding pregnancy 
    Unplanned pregnancy 
 
115 (67.7) 
  
Focus group discussion participants  
Median age (IQR) 29.5 (26-35.5) 
Marital status 
    Married 
 
4 (25) 
Cohabitation status 
    Cohabiting 
 
8 (50) 
Number of weeks pregnant at time of interview 
    Second trimester 
    Third trimester 
 
3 (19) 
13 (81) 
Gravidity 
    First pregnancy 
 
4 (25) 
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Survey results: 
Disclosure: 
Most participants (95%) had been tested for HIV prior to their current pregnancy, with 44% 
testing during a previous pregnancy. The primary reasons reported for testing outside of 
pregnancy included curiosity; experience of HIV symptoms; and the offer of routine testing 
at a health facility. Participants reported high rates of HIV-related discussion with their 
partners, with 80% reporting that they had discussed HIV testing, and 88% reporting that they 
had discussed preventing horizontal transmission of HIV (Table 2).  
 
Table 2 HIV testing, discussion, and treatment  
Variable n (%) 
Testing prior to current pregnancy  
    Tested prior to current pregnancy 
    Not previously tested 
 
161 (94.7) 
9 (5.3) 
Testing outside of pregnancy (n = 161) 
    Tested during a previous pregnancy 
    Tested outside of pregnancy 
 
71 (44.1) 
90 (55.9) 
HIV-related discussion  
    Has discussed HIV-testing with partner 136 (80.0) 
    Has discussed preventing horizontal transmission with partner 149 (87.7) 
ARV regimen at time of interview 
    Short-course AZT 
    Life-long ART 
    FDC 
 
15 (8.8) 
30 (17.7)  
125 (73.5)  
Adherence during current pregnancy 
    Participant reports complete adherence 
    Participant reports non-adherence 
 
134 (78.8)  
36 (21.2)  
 
 
Seventy-four percent (n=126) of the participants reported that they had disclosed their HIV-
status to their partner. Reasons for disclosure included to make taking ARVs easier; to 
facilitate condom use; and to encourage male partner testing. Only 54% of the participants 
reported that they knew their partner’s HIV-status, with 17% (n=29) reporting that they knew 
because they tested together (Table 3).  
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Table 3 Disclosure and male partner involvement  
Variable n (%) 
Disclosure to partner 
    Participant has not disclosed  
    Participant has disclosed  
 
44 (25.9) 
126 (74.1)  
Knowledge of partner’s HIV status 
    Participant does not know partner’s status 
    Participant knows partner’s status 
 
79 (46.5)  
91 (53.5)  
Male partner involvement (n = 169) 
    Provides financial support for participant’s antenatal visits 
    Knows when participant’s antenatal visits are 
    Discusses with participant what happens during antenatal visits 
    Accompanies participant to antenatal visits 
    Reported partner discussion of PMTCT     
 
144 (85.2)  
161 (95.3)  
162 (95.9)  
59 (34.9)  
151 (89.3)  
Male partner involvement score (n = 169) 
    0 
    1 
    2 
    3 
    4 
    5 
 
2 (1.2)  
4 (2.4)  
6 (3.6)  
17 (10.1)  
90 (53.3)  
50 (29.6)  
 
 
In crude analyses, disclosure to one’s partner was significantly more likely among 
participants who were married (OR = 3.5; 95% CI: 1.2-12.2) or cohabiting (OR = 3.2; 95% 
CI: 1.4-7.1); among participants who knew their partner’s HIV-status (OR = 10.6; 95% CI: 
4.1-30.1); and among participants who reported higher levels of HIV-related discussion with 
their partner (OR = 20.2; 95% CI: 7.8-53.7). In a multiple logistic regression model, 
knowledge of one’s partner’s HIV-status and higher levels of HIV-related discussion 
remained significantly associated with disclosure, when controlling for marital status (Table 
4). Those who knew their partner’s status were 8.8 (95% CI: 3.1-25.1) times more likely to 
have disclosed than those who did not know their partner’s status. Those who reported higher 
levels of HIV-related discussion were 18.2 (95% CI: 6.6-50.1) times more likely to have 
disclosed than those who reported low levels of discussion.   
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Table 4 Factors associated with disclosure to partner 
Variable Unadjusted odds ratio (95% CI) P-value 
Marital status 
    Not married 
    Married 
 
Reference 
3.5 (1.2-12.2) 
 
 
0.011 
Cohabitation status 
    Not cohabiting with partner 
    Cohabiting with partner      
 
Reference 
3.2 (1.4-7.1) 
 
 
0.002 
Knowledge of partner’s HIV status 
    Participant does not know partner’s status 
    Participant knows partner’s status 
 
Reference 
10.6 (4.1-30.1) 
 
 
<0.001 
Discussion score 
    Low 
    High 
 
Reference 
20.2 (7.8-53.7) 
 
 
<0.001 
Variable Adjusted odds ratio (95% CI) P-value 
Knowledge of partner’s HIV status 
    Participant does not know partner’s status 
    Participant knows partner’s status 
 
Reference 
8.8 (3.1-25.1) 
 
 
<0.001 
Discussion score 
    Low 
    High 
 
Reference 
18.2 (6.6-50.1) 
 
 
<0.001 
Marital status 
    Not married 
    Married 
 
Reference 
3.3 (0.9-12.0) 
 
 
0.066 
 
Adherence: 
All of the participants were on ART, with 74% of the participants taking a fixed-dose 
combination regimen. Seventy-nine percent (n=134) of participants reported that they had not 
missed a dose during their current pregnancy (Table 2). Reasons for non-adherence included 
that the participants were away from home and did not have their ARVs with them, or that 
they were newly initiated and were not yet accustomed to taking them. Adherence was 
significantly higher among older participants compared to younger participants (p=0.008), 
however, adherence was not significantly associated with any other variables in bivariate or 
multivariate models. 
 
Seventy-four percent (n=125) of the participants reported that their partners were aware that 
they were taking ARVs, and the majority of partners who were aware of this (95%) 
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reportedly helped them to adhere. The most frequently reported way in which partners 
provided this support was by reminding participants to take their ARVs. Taking their ARVs 
at the same time as their partners was also described as a way in which partners were 
supportive.  
 
Male partner involvement: 
Most participants indicated that their partners provided financial support for their antenatal 
visits (85%); knew when their antenatal visits were (95%); discussed with them what happens 
during antenatal visits (96%); and had discussed with them ways to prevent MTCT (89%). 
However, only 35% of participants reported that their partners accompanied them to antenatal 
visits (Table 3). The majority of participants reported that they desired high rates of MPI, and 
that MPI is deemed normative in their community.  
 
In crude analyses, high involvement was significantly more likely among participants who 
had a previous pregnancy (OR = 2.9; 95% CI: 1.0-7.8); those who were married (OR = 3.6; 
95% CI: 1.0-19.4) or cohabiting (OR = 9.7; 95% CI: 3.1-39.8); those who had disclosed (OR 
= 8.7; 95% CI: 3.3-23.4) or knew their partner’s HIV-status (OR = 4.7; 95% CI: 1.8-13.8); 
and those who reported high levels of HIV-related discussion with their partners (OR = 21.3; 
95% CI: 7.3-66.1). In a multiple logistic regression model, high MPI remained significantly 
associated with cohabitation status and high levels of HIV-related discussion, when 
controlling for disclosure (Table 5). Those who were cohabiting were 7 (95% CI: 2.0-24.0) 
times more likely to report high MPI compared to those who were not cohabiting. Those who 
reported high levels of HIV-related discussion were 13.2 (95% CI: 3.8-45.4) times more 
likely to report high MPI compared to those who reported low levels of HIV-related 
discussion. 
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Table 5 Factors associated with male partner involvement 
Variable Unadjusted odds ratio (95% CI) P-value 
Gravidity 
    First pregnancy 
    Has previously been pregnant 
 
Reference 
2.9 (1.0-7.8) 
 
 
0.029 
Marital status 
    Not married  
    Married  
 
Reference 
3.6 (1.0-19.4) 
 
 
0.034 
Cohabitation status 
    Not cohabiting  
    Cohabiting  
 
Reference 
9.7 (3.1-39.8) 
 
 
<0.001 
Knowledge of partner’s status 
    Does not know partner’s status 
    Knows partner’s status 
 
Reference 
4.7 (1.8-13.8) 
 
 
<0.001 
Disclosure 
    Has not disclosed to partner 
    Has disclosed to partner 
 
Reference 
8.7 (3.3-23.4) 
 
 
<0.001 
HIV-related discussion 
    Low 
    High      
 
Reference 
21.3 (7.3-66.1) 
 
 
<0.001 
Variable Adjusted odds ratio (95% CI) P-value 
Cohabitation status 
    Not cohabiting     
    Cohabiting  
 
Reference 
7.0 (2.0-24.0) 
 
 
0.002 
HIV-related discussion 
    Low 
    High 
 
Reference 
13.2 (3.8-45.4) 
 
 
<0.001 
Disclosure 
    Has not disclosed to partner 
    Has disclosed to partner 
 
Reference 
1.7 (0.5-5.7) 
 
 
0.404 
   
 
Focus group discussion results: 
Disclosure: 
The FGD participants discussed facilitators of disclosure, with several participants citing 
counselling from health workers on how to disclose as being supportive. However, the 
majority of participants emphasised barriers to disclosure, with the primary barrier being fear. 
Women feared that disclosure would precipitate a violent reaction from their partner; amount 
to blame for infection; cause conflict within the relationship or result in the relationship 
ending. The participants agreed that partner disclosure felt different to disclosing to family 
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members, due to the risk of the partner ending the relationship. Despite these fears, 
participants acknowledged that partner disclosure is crucial. Two of the participants reported 
that disclosure had led to unexpected positive outcomes – notably providing the context for 
the partner to disclose his HIV-positive status, or resulting in male partner testing.  
 
In addition, HIV testing outside of pregnancy was deemed important, because a positive 
diagnosis during pregnancy could invoke bitterness and resentment, subsequently putting the 
baby’s health at risk. Although none of the FGD participants had received couple counselling 
and testing, and most remarked that they had never seen this being offered, many participants 
supported the idea and would have appreciated the opportunity for couples testing. One 
participant suggested that pregnant women be given written instructions from antenatal staff 
to bring their partners to the facility on a specific date in order to undergo couple testing.  
 
Adherence:  
Participants discussed their partner’s role in ARV adherence. Ways in which partners could 
be supportive included reminding the participants to take their ARVs; bringing their ARVs 
with a glass of water; and fetching ARVs from the clinic. Participants described how it made 
them feel special and loved when their partners took care of them in this way. A participant 
described that it was helpful to take her ARVs at the same time as her partner.  
 
Male partner involvement 
FGD participants described pregnancy as an important and expected role of women in their 
community. Pregnancy among unmarried women was perceived as common and was 
considered the norm. Many of the participants described marriage as an outdated tradition 
with little societal value. There was unanimous agreement that pregnancy is a shared 
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responsibility, in which a man’s role is to be loving, supportive, and helpful. Examples put 
forward of ways in which partners could be supportive during pregnancy included helping at 
home; looking after other children; enquiring about the pregnancy and the content of the 
antenatal visits; providing money to go to the clinic; reminding her of her antenatal visit 
dates; giving her massages; and washing her legs and feet when advanced pregnancy made 
this difficult. 
 
Two contrasting forms of masculinity were described in the FGDs. While some men seemed 
willing to take care of a baby and a family, others were not. The latter saw such work as 
undermining their masculinity. The participants described that while some men were present 
and involved during pregnancy, other men were not. In addition, many of the FGD 
participants who had received support from their partners during previous pregnancies stated 
that this support was limited to pregnancy. One of the participants described increased 
support as stemming from her partner’s sense of masculinity and fatherhood in response to 
her pregnancy. 
 
Although the FGD participants all agreed that they would like their partners to accompany 
them to antenatal visits, they discussed how men who do accompany their partners are 
prevented from entering the clinic by security guards, which makes them unwilling to 
accompany their partners. Men were forced by security guards to wait outside due to 
overcrowding inside. Despite this, women supported a male-friendly facility, because they 
wanted their partners to be informed during antenatal visits and the pregnancy. The 
participants agreed that it would not be feasible or necessary for partners to accompany them 
to every antenatal visit, but suggested that partner attendance be made compulsory for at least 
one visit to allow for couple testing.  
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Discussion: 
This research explored MPI during pregnancy as a potentially useful intervention to facilitate 
PMTCT and promote family-based care. Among the participants interviewed, most had 
previously been pregnant, and had tested prior to their current pregnancy. However, testing 
had not necessarily been linked to a previous pregnancy. As reported elsewhere, gender 
inequalities which challenge the uptake of HIV testing and disclosure in pregnancy were 
found, including disparities in age, education, and employment between participants and their 
partners [16].  Despite these obstacles, high rates of discussion around testing, sexual 
transmission, and PMTCT were reported, suggesting the normalisation of HIV, as reported in 
other South African settings [17]. 
 
This high reported rate of HIV-related discussion with partners is encouraging, particularly as 
high levels of discussion were found to be significantly associated with both disclosure and 
MPI in multivariate analysis. This is consistent with the view that men who are supportive of 
their pregnant partners were presumably already supportive and involved prior to the 
pregnancy, and may not represent the majority [18]. The importance of communication 
within couples has additionally been highlighted in a review of MPI in sub-Saharan Africa, 
where poor communication within couples was reported as a barrier to the uptake of HIV 
testing among women and to male attendance of antenatal care [19]. 
 
Our research shows that women felt it important to test for HIV outside of pregnancy, mostly 
to avoid disappointment and bitterness associated with discovering one’s HIV-positive status 
during pregnancy. Just over half of the survey participants had tested outside of pregnancy. 
This indicates a possible shift in testing behaviours among this population from antenatal care 
formerly providing a gateway to testing and HIV care [20]. Only a small proportion of survey 
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participants reported that they had tested with their partner. This proportion, while low, is 
encouraging, as it indicates some willingness to pursue couple testing. However, couple-
centred approaches to HIV testing and prevention remain rare in sub-Saharan Africa [21]. It 
is likely that low levels of couple testing are attributable to service-related factors, such as 
poor availability of staff and appropriate venues for couples counselling.   
 
Disclosure among the survey participants to their male partners was unexpectedly high (74%) 
compared to other South African and African settings (22, 23, 24). Disclosure was more 
common among participants who were married, which is consistent with previous research 
conducted in Tshwane, South Africa, which found that pregnant women who were married 
were significantly more likely to disclose to their partners than those who were not married to 
their partners [22]. Documented challenges to disclosure in South African PMTCT settings 
have included both single marital status and unplanned pregnancy, both of which were 
prevalent in this study [23]. Furthermore, our results suggest that little value is currently 
placed in marriage, a perspective that has been documented in other South African research, 
which reports low rates of marriage and high rates of sexual partnerships outside of marital 
and cohabiting relationships [25]. Hence different types of relationships could influence the 
nature and extent of MPI in PMTCT [4].  
 
This study demonstrated that partner disclosure is not a two-way process. Our results show 
that reported disclosure was weighted more heavily towards female-to-male disclosure than 
male-to-female disclosure, which is consistent with the results of another study in 
Mpumalanga, South Africa [26]. Common challenges to disclosure experienced by women, 
notably the fear of violence and rejection, still seem prevalent, as found in previous research 
[23]. While this again raises the issue of gendered power dynamics in disclosure, the fairly 
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high proportion of participants who had disclosed to their partners in the present study is 
encouraging. The FGD participants discussed their fears regarding disclosure, which again 
raises the issue of how much women believe that they have to lose by disclosing.  
 
Encouragingly, however, the participants acknowledged that despite these fears, disclosure to 
one’s partner is vital. As reported in a study in Mpumalanga, South Africa, one of the 
primary reasons for disclosing put forward by our participants was to encourage their partners 
to get tested [27]. This shows a possible shift in disclosure behaviour, as it shows how, 
regardless of the fear related to disclosure, many women weigh up the possible benefits and 
are disclosing to their partners.  
 
Reported rates of adherence among the survey participants were fairly high, with 79% of 
participants reporting that they had not missed a dose during pregnancy. The rate of 
adherence may be due to the fact that the majority of participants were on a FDC regimen, 
which is easier to manage. However, it may have also been too early in the course of 
treatment to estimate adherence effectively. Furthermore, adherence may be higher in 
pregnancy because women are intent on preventing MTCT.  
 
As stated above, many survey participants reported high levels of MPI in a range of activities. 
It appears as though there has been a shift in perceptions of MPI within this population, as an 
earlier study (2004-2005) conducted in Khayelitsha reported that female FGD participants 
described MPI as consisting solely of men accompanying their female partners to antenatal 
visits [10]. From our findings, it appears that gender norms have shifted and that men are now 
more involved in pregnancy. In addition, most survey participants who had disclosed 
received adherence support from their partners. A high level of MPI was significantly more 
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likely among participants who were cohabiting, which is consistent with the results of a 
review of MPI in sub-Saharan Africa [7], as well as with the results of another review of MPI 
in which it was found that one of the primary facilitators of MPI is being in a stable 
relationship [28].  
 
Regardless of the reported contrasting range of MPI activities, financial support and 
discussion around antenatal care were reported in the survey as the most prevalent partner 
involvement activities. Being able to attend antenatal visits depends on several factors [13], 
and attendance may be constrained by health facility barriers. It is thus argued that targeted 
interventions for men while their partners are pregnant may be more beneficial than 
attempting to increase rates of male attendance at antenatal visits [29].A few male partners in 
the present study, however, accompanied women to the antenatal service, which is consistent 
with the results of a study conducted in Durban, South Africa [6].  
 
The FGD participants all expressed a desire for their partners to accompany them to antenatal 
visits, but reported health facility barriers to this. In addition, as reported elsewhere, our 
research found that men who were forced to wait outside questioned the necessity of 
accompanying their partners to the clinic [18]. 
 
As mentioned above, the FGD participants experienced two contrasting forms of masculinity. 
In multivariate analysis of the survey data, a high level of HIV-related discussion within the 
couple was significantly associated with both disclosure and MPI. It thus appears as though it 
is a certain type of male who becomes highly involved in his partner’s pregnancy. Non-
governmental organizations which run campaign messages regarding responsible relationship 
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building and parenting, such as “Brothers for Life”, thus aim to engage men and target gender 
inequity in an attempt to promote MPI and fatherhood in South Africa [30].  
 
This study has several limitations. First, while the fairly high disclosure rate found among the 
survey participants is encouraging, the possibility that female-male partner disclosure was 
over-reported due to social desirability bias cannot be excluded, and is thus a limitation of the 
methodology used. Similarly, the high reported rate of HIV-related discussion may have been 
influenced by social desirability bias. Adherence was also self-reported in this study, and may 
have been subject to recall bias and/or social desirability bias.  
 
As is evident in the wide confidence intervals, the results of this study lack precision, 
possibly due to the small sample size, but this is not uncommon in formative research. As the 
study was conducted using a convenience sample at only one antenatal service, the results 
may not be generalizable to other contexts, as the high HIV prevalence as well as the high 
levels of unemployment, violence, and migration in this context may have influenced the 
outcomes. Given the scope of this research and the resources at hand, it was not possible to 
interview men. Hence, some of the views concerning MPI expressed by the women 
interviewed may present a biased perspective of the extent of MPI in this population. Given 
the lack of a precise definition of MPI and validated tool to assess involvement, MPI may 
have been overestimated in the present study based on the definition and tool used. Men may 
have been misclassified as highly involved in PMTCT itself when they were in reality more 
involved in pregnancy than in PMTCT, especially in cases where disclosure had not taken 
place. Research of men’s perspectives of MPI would thus be useful.   
 
67 
 
Conclusion: 
The results of this study highlight the importance of the need for interventions which 
facilitate partner disclosure, with particular support for male partners, given the lack of 
balance in reported disclosure rates. Services that promote and facilitate couples counselling, 
as well as the provision of psychosocial support for HIV concordant and discordant couples, 
should be explored. In addition, our findings highlight the potential to intervene at the level 
of the couple in order to increase MPI. As higher levels of discussion were found to be 
associated with MPI, and men who communicate with their partners appear to be more likely 
to participate in PMTCT programmes [4], interventions should target communication within 
the couple, and this should preferably occur before pregnancy. The varied nature of 
partnerships needs to be accounted for in MPI interventions.  Given that different ‘types’ of 
masculinities were identified in relation to MPI, this also suggests that interventions need to 
target dynamics within the couple prior to pregnancy.  
 
There is a need to move towards accepting men as integral partners in promoting family 
health [4]. Interventions should aim to increase involvement in a variety of activities, and 
should not focus on antenatal attendance alone. However, encouraging partners to attend at 
least one antenatal appointment should perhaps be explored, as it would allow for couples 
testing and would facilitate disclosure. An alternate strategy which was tested in the context 
of a randomized clinical trial in Kenya was that of home-based couple counselling and 
testing, which was found to significantly increase the number of male partners reached and 
tested [31]. Given the barriers to male attendance at antenatal services, this strategy should 
perhaps be explored in other contexts. 
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The integration of male partners could strengthen all four pillars of PMTCT. HIV testing and 
counselling around behaviour change among men has the potential to greatly reduce the 
incidence of HIV in women of reproductive age. As male partners are often decision-makers 
within the couple, the integration of male partners may be essential for family planning in 
certain contexts. In addition, there is evidence that MPI is beneficial in terms of infant 
outcomes in PMTCT, and men should be, in their role as fathers, integral partners in ensuring 
care and support for their children. The argument can thus be made for increased efforts to 
promote MPI in PMTCT and in subsequent fatherhood. 
 
 
 
 
 
 
 
 
 
 
 
 
 
69 
 
References: 
1. Goga A, Dinh T, Jackson D, The SAPMTCTE Study Group. Population-level impact 
of the national PMTCT programme: 2010 and 2011. A decade of PMTCT – 
celebrating success. PMTCT Symposium; 2012 Oct 23-24. Johannesburg.  
2. Barron P, Pillay Y, Doherty T, et al. Eliminating mother-to-child HIV transmission in 
South Africa. Bull World Health Organ. 2013;91:70–74. 
3. Betancourt TS, Abrams EJ, McBain R, Smith Fawzi MC. Family-centred approaches 
to the prevention of mother to child transmission of HIV. J Int AIDS Soc. 
2010;13(Suppl 2):S2. 
4. World Health Organization. Male involvement in the prevention of prevention of 
mother-to-child transmission of HIV. Switzerland: World Health Organization; 2012. 
5. Peltzer K, Sikwane E, Majaja M. Factors associated with short-course antiretroviral 
prophylaxis (dual therapy) adherence for PMTCT in Nkangala district, South Africa. 
Acta Paediatr. 2011;100:1253–1257. 
6. Maman S, Moodley D, Groves AK. Defining male support during and after pregnancy 
from the perspective of HIV-positive and HIV-negative women in Durban, South 
Africa. J Midwifery Womens Health. 2011;56(4):325–331. 
7. Ditekemena J, Koole O, Engmann C, et al. Determinants of male involvement in 
maternal and child health services in sub-Saharan Africa: A review. Reprod Health. 
2012;9:32. 
8. Alio AP, Lewis CA, Scarborough K, Harris K, Fiscella K. A community perspective 
on the role of fathers during pregnancy: a qualitative study. BMC Pregnancy 
Childbirth. 2013;13:60. 
9. Stinson K, Giddy J, Cox V, et al. Reflections on a decade of delivering PMTCT in 
Khayelitsha, South Africa. S Afr J HIV Med. 2014;15(1):30. 
70 
 
10. Mohlala BKF, Gregson S, Boily M. Barriers to involvement of men in ANC and VCT 
in Khayelitsha, South Africa. AIDS Care. 2012;24(8):972-977. 
11. Weiss SM, Peltzer K, Villar-Loubet O, Shikwane ME, Cook R, Jones DL. Improving 
PMTCT uptake in rural South Africa. J Int Assoc Provid AIDS Care. 2013. 
12. NIAID AIDS Clinical Trials Group. Adherence Interview – II. 2010.  
13. Montgomery E, van der Straten A, Torjesen K. “Male involvement” in women and 
children’s HIV prevention: challenges in definition and interpretation. J Acquir 
Immune Defic Syndr [Letter to the editor]. 2011;57(5):e114-e116. 
14. Byamugisha R, Tumwine JK, Semiyaga N, Tylleskär T. Determinants of male 
involvement in the prevention of mother-to-child transmission of HIV programme in 
Eastern Uganda: a cross-sectional survey. Reprod Health. 2010;7:12. 
15. Green J, Thorogood N. Qualitative methods for health research. 2nd ed. London: 
SAGE; 2009. 
16. Ghanotakis E, Peacock D, Wilcher R. The importance of addressing gender inequality 
in efforts to end vertical transmission of HIV. J Int AIDS Soc. 2012;15(Suppl 
2):17385. 
17. Zuch M, Lurie M. “A virus and nothing else”: the effect of ART on HIV-related 
stigma in rural South Africa. AIDS Behav. 2012;16:564-570. 
18. Larsson EC, Thorson A, Nsabagasani X, Namusoko S, Popenoe R, Ekström AM. 
Mistrust in marriage – reasons why men do not accept couple HIV testing during 
antenatal care – a qualitative study in eastern Uganda. BMC Public Health. 
2010;10:769. 
19. Kalembo FW, Yukai D, Zgambo M, Jun Q. Male partner involvement in prevention 
of mother to child transmission of HIV in sub-Saharan Africa: successes, challenges 
and way forward. Open J Prev Med. 2012;2(1):35-42. 
71 
 
20. Abrams EJ, Myer L, Rosenfield A, El-Sadr WM. Prevention of mother-to-child 
transmission services as a gateway to family-based human immunodeficiency virus 
care and treatment in resource-limited settings: rationale and international 
experiences. Am J Obstet Gynecol. 2009:S101-S106. 
21. Desgrées-du-Loû A, Orne-Gliemann J. Couple-centred testing and counselling for 
HIV serodiscordant heterosexual couples in sub-Saharan Africa. Reprod Health 
Matters. 2008;16(32):151-161. 
22. Makin JD, Forsyth BWC, Visser MJ, Sikkema KJ, Neufeld S, Jeffery B. Factors 
affecting disclosure in South African HIV-positive pregnant women. AIDS Patient 
Care STDS. 2008;22(11):907-916. 
23. Crankshaw TL, Voce A, King RL, Giddy J, Sheon NM, Butler LM. Double disclosure 
bind: complexities of communicating an HIV diagnosis in the context of unintended 
pregnancy in Durban, South Africa. AIDS Behav. 2013. 
24. Roxby AC, Matemo D, Drake AL et al. Pregnant women and disclosure to sexual 
partners after testing HIV-1–seropositive during antenatal care. AIDS Patient Care 
STDS. 2013;27(1):33-37. 
25. Department of Health, Medical Research Council. South Africa demographic and 
health survey 2003. Pretoria: Department of Health; 2007. 
26. Peltzer K, Jones D, Weiss SM, Villar-Loubet O, Shikwane E. Sexual risk, serostatus 
and intimate partner violence among couples during pregnancy in rural South Africa. 
2013;17:508-516. 
27. Villar-Loubet OM, Bruscantini L, Shikwane ME, Weiss S, Peltzer K, Jones D.L. HIV 
disclosure, sexual negotiation and male involvement in prevention-of-mother-to-
child-transmission in South Africa. Cult Health Sex. 2013;15(3): 253–268. 
72 
 
28. Morfaw F, Mbuagbaw L, Thabane L, et al. Male involvement in prevention programs 
of mother to child transmission of HIV: a systematic review to identify barriers and 
facilitators. Syst Rev. 2013;2:5. 
29. Jones DL, Peltzer K, Villar-Loubet O, et al. Reducing the risk of HIV infection during 
pregnancy among South African women: a randomized controlled trial. AIDS Care. 
2013. 
30. Sonke Gender Justice. Brothers for life [Internet]. [cited 2014 Feb 6]. Available from: 
http://www.genderjustice.org.za/projects/brothers-for-life.html 
31. Osoti AO, John-Stewart G, Kiarie J et al. Home visits during pregnancy enhance male 
partner HIV counselling and testing in Kenya: a randomized clinical trial. AIDS. 
2014;28(1):95–103. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
73 
 
 
 
 
 
 
 
 
 
 
 
 
PART D: APPENDICES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
74 
 
Appendix 1: Quantitative component: Information sheet and informed 
consent form: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Informed Consent Form: 
 
The purpose of the study has been explained to me, as well as what I can expect if I decide to 
participate. I have had the opportunity to ask questions about these, and these questions have been 
answered to my satisfaction.  
 
I understand that the answers I provide will be confidential and that my identity will be kept 
anonymous. 
 
I consent voluntarily to participate in this study and I understand that I have the right to withdraw 
from the study at any time without this affecting my antenatal treatment in any way or leading to any 
negative consequences. 
 
Participant’s signature (or a tick if you would prefer): ________________       Date: ______________ 
 
Signature of investigator: __________________             Date: _____________ 
 
Thank you. 
Male partner involvement during pregnancy:  
The missing component in PMTCT adherence in Khayelitsha? 
 
We are from the school of Public Health and Family Medicine at the University of Cape Town. We are 
collecting information about male partner involvement in pregnancy, specifically when the pregnant woman is 
HIV-positive. We are interested in finding out what your experience of male partner involvement in your 
pregnancy is, as well as your experience of being on an antiretroviral regimen during pregnancy. Although 
participating in this study will not benefit you directly, and payment will not be provided for participating, we 
hope that this research will provide insight into how programmes which aim to prevent mother-to-child 
transmission of HIV can be improved.  
 
Your participation in this study is voluntary, and if you decide not to participate then you will face no negative 
consequences. This study is not being conducted by any antenatal service, so if you decide not to participate 
then your antenatal treatment will not be affected in any way. We will not record your name during the 
interview, nor use it in our research. You are also free to withdraw from the study at any time or refuse to 
answer any specific questions, should you wish to do so.   
 
If you decide to participate in the study, you can expect the following: 
 An interviewer will ask you questions and write down your answers. This should not take longer than 
20 minutes. 
 All of your answers to the questions will be kept private and confidential, and your name and anything 
that could be used to identify you will not be recorded. Only the researchers on this study will see your 
answers. 
 Participation in this study will involve only minimal risks. Every effort will be made by the researchers 
to minimise the possible negative consequences of participating.  
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Appendix 2: Qualitative component: Information sheet and informed 
consent form: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Male partner involvement during pregnancy:  
The missing component in PMTCT adherence in Khayelitsha? 
 
We are from the school of Public Health and Family Medicine at the University of Cape Town. We are 
collecting information about male partner involvement in pregnancy, specifically when the pregnant woman is 
HIV-positive. We are interested in finding out what your experience of male partner involvement in your 
pregnancy is, as well as your experience of decision-making in pregnancy and of HIV testing. Although 
participating in this study will not benefit you directly, and payment will not be provided for participating, we 
hope that this research will provide insight into how programmes which aim to prevent mother-to-child 
transmission of HIV can be improved.  
 
Your participation in this study is voluntary, and if you decide not to participate then you will face no negative 
consequences. This study is not being conducted by any antenatal service, so if you decide not to participate then 
your antenatal treatment will not be affected in any way. We will not record your name during the group 
discussion, nor use it in our research. You are also free to withdraw from the study at any time or refuse to 
answer any specific questions, should you wish to do so.   
 
If you decide to participate in the study, you can expect the following: 
 You will be part of a focus group, which is a group discussion on various topics. In this study, the topics 
will be decision-making in pregnancy, HIV testing, and male partner involvement in pregnancy. All of 
the group members will be HIV-positive pregnant women.  
 The group discussion will be facilitated by a research assistant who will ask the group questions on the 
above topics. The group discussion will be recorded, but your name and anything that could be used to 
identify you will not appear anywhere in the data in order to keep your identity anonymous. 
 The group discussion will last for approximately 1 – 1½ hours. 
 Participation in this study will involve only minimal risks. Every effort will be made by the researchers 
to minimise the possible negative consequences of participating.  
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Informed Consent Form: 
 
The purpose of the study has been explained to me, as well as what I can expect if I decide to 
participate. I have had the opportunity to ask questions about these, and these questions have been 
answered to my satisfaction.  
 
I understand that my identity will be kept anonymous. 
 
I consent voluntarily to participate in this study and I understand that I have the right to withdraw 
from the study at any time without this affecting my antenatal treatment in any way or leading to any 
negative consequences. 
 
I understand that the focus group discussion will be recorded (audio only), and I consent voluntarily to 
this. 
 
Participant’s signature (or a tick if you would prefer): _________________       Date: ____________ 
 
Signature of investigator: ____________________                          Date: ____________ 
 
Thank you.  
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Appendix 3: Quantitative component: Questionnaire: 
 
1. Questions about yourself: 
 
1.1 How old are you? _____ years 
 
1.2 Which race group do you consider yourself to belong to? 
   
  
 
 
 
             Other: ____________  
 
1.3 What language do you speak at home?  
 
 
 
 
                          Other: __________________ 
 
1.4 What is the highest level of education that you have completed?  
 
  
  
 
 
 
 
 
 
1.5 What is your current employment status? 
 
 
 
 
1.6 If you are currently employed, what is your occupation? ___________ 
 
1.7 What is your major source of income?  
 
 
                      
 
 
 
                        Other: _____________ 
 
 
Black/African  
Coloured  
Indian/Asian  
White  
English  
isiXhosa  
Afrikaans  
Primary school  
Grade 8 (Standard 6)  
Grade 9 (Standard 7)  
Grade 10 (Standard 8)  
Grade 11 (Standard 9)  
Grade 12 (Standard 10/Matric)  
Diploma  
Degree  
Unemployed  
Employed part-time  
Employed full-time  
Your work   
Your husband/partner  
Other family or household member  
Social grant (for example Child Support Grant)  
Pension  
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2. Questions about your child: 
 
2.1 How many weeks pregnant are you? __________ 
 
2.2 How many weeks pregnant were you when you came to the antenatal clinic for your 
booking visit? ________ 
 
2.3 Is this your first pregnancy? 
 
 
2.4 If this is not your first pregnancy, how many other children do you have?  
___________________________________________________________________________ 
 
2.5 Who made the decision to have a child? 
 
  
 
 
 
  
If other family members made the decision, specify who they are (their relationship to you): 
___________ 
 
2.6 Who do you think should make the decision regarding if and when a woman should have 
a child? 
 
 
 
 
 
 
3. Questions about your relationship with the father of your child: 
 
3.1Are you married to the father of your child?  
 
 
3.2 If yes, how long have you been married to him for? ____ years 
 
3.3 Do you currently live with the father of your child?  
 
 
3.4 If yes, how long have you been living with him for? ____ years 
 
3.5 If you are living with the father of your child, how present is he in the home?  
 
 
 
 
 
                   Other: ______________ 
Yes  No  
The pregnancy was not planned  
I made the decision  
The father of my child made the decision  
We made the decision together   
Other family members made the decision  
The woman should make the decision  
The woman’s partner should make the decision  
The woman and her partner should make the decision together   
Other family members should make the decision  
Yes  No  
Yes  No  
He is there during the day  
He is only there in the evenings  
He is only there over weekends  
He is there every few weeks  
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3.6 How old is the father of your child? ____ years  
 
3.7 What is the highest level of education that the father of your child has completed?  
 
  
 
 
 
 
 
 
 
 
3.8 What is the father of your child’s current employment status?  
 
 
 
 
 
3.9 If he is currently employed, what is his occupation? ______________ 
 
 
4. Questions about HIV: 
 
4.1 Had you ever been tested for HIV before you attended your booking visit at the antenatal 
clinic for your current pregnancy?  
 
  
4.2 If you had been tested before, was your previous test linked to another pregnancy?  
 
 
4.3 If you had been tested before when you were not pregnant, what was your reason for 
getting tested? 
___________________________________________________________________________
___________________________________________________________________________ 
 
4.4 In what year did you test positive? ____________ 
 
4.5 Have you ever discussed HIV testing with the father of your child?  
 
 
4.6 Do you know what the father of your child’s HIV status is?  
 
 
4.7 If you do know his status, how did you find out what his status is? 
 
 
 
                   Other: ______________________________ 
Primary school  
Grade 8 (Standard 6)  
Grade 9 (Standard 7)  
Grade 10 (Standard 8)  
Grade 11 (Standard 9)  
Grade 12 (Standard 10/Matric)  
Diploma  
Degree  
Unknown  
Unemployed  
Employed part-time  
Employed full-time  
Unknown  
Yes  No  
Yes  No  
Yes  No  
Yes  No  
He told me   
We were tested together  
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4.8 Have you ever discussed ways to prevent partner transmission of HIV with the father of 
your child?  
 
 
4.9 Have you ever discussed ways to prevent transmitting HIV to your child with the father 
of your child?  
 
 
4.10 Are you currently on an antiretroviral regimen (ARVs)?  
 
 
4.11 Are you on a short-course PMTCT prophylaxis regimen (AZT, which you only have to 
take while you are pregnant), a life-long ART regimen (where you take three different 
tablets/drugs), or a fixed dose combination (where you only take one tablet/drug)?  
 
 
 
 
4.12 In what year did you start taking ARVs? __________ 
 
4.13 How many doses of your ARVs are you supposed to take each day? ______ 
 
4.14 During the last 30 days, on how many days did you miss at least one dose of any of your 
ARVs? ______ 
 
4.15 During the last week, on how many days did you miss at least one dose of any of your 
ARVs? ______ 
 
4.16 How many doses of your ARVs did you miss yesterday? _____ 
 
4.17 How many doses of your ARVs did you miss the day before yesterday? _____ 
 
4.18 Have you missed any doses of your ARVs while you have been pregnant?  
 
 
4.19 If you have missed any doses of your ARVs while you have been pregnant, when was 
the last time you missed any of your ARVs? 
 
 
 
 
 
 
 
4.20 If you have missed doses of your ARVs while you have been pregnant, please explain 
why you were unable to always take the correct dosage: 
___________________________________________________________________________
___________________________________________________________________________ 
 
 
Yes  No  
Yes  No  
Yes  No  
Short-course AZT  
Life-long ART  
Fixed dose combination  
Yes  No  
Within the past week  
1-2 weeks ago  
2-4 weeks ago  
1-2 months ago  
More than 2 months ago  
Never miss ARVs  
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5. Questions about disclosure: 
 
5.1 Have you told your partner your HIV status?  
 
 
5.2 Why did you decide to tell him/not tell him? 
___________________________________________________________________________
___________________________________________________________________________ 
 
5.3 If you have told your partner your HIV status, when did you tell him? 
Before I was pregnant  
While I was pregnant  
 
5.4 If you have not told your partner your HIV status, have you told anyone else?  
 
 
5.5 If you have told someone else your HIV status, what is your relationship with that 
person? Please select all of the people who you have told: 
 
 
                                    
 
 
 
                   Other (for example a traditional healer, priest, another pregnant woman, a  
                    community health worker etc): _________________________________           
 
 
6. Questions about the father of your child’s role in your pregnancy: 
 
6.1 Does the father of your child do each of the following?      
 Yes No 
Provides financial support for my antenatal visits   
Knows when my antenatal visits are   
Discusses what happens during antenatal visits with me   
Accompanies me to antenatal visits   
 
6.2 Would you like the father of your child to do each of the following?  
 Yes No 
Provide financial support for my antenatal visits   
Know when my antenatal visits are   
Discuss what happens during antenatal visits with me   
Accompany me to antenatal visits   
 
 
 
 
 
 
Yes  No  
Yes  No  
Mother  
Father  
Sibling  
Any other family member   
Friend  
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6.3 In your community, is it normal/acceptable for the father of your child to do each of the 
following?  
 Yes No 
Provide financial support for my antenatal visits   
Know when my antenatal visits are   
Discuss what happens during antenatal visits with me   
Accompany me to antenatal visits   
 
6.4 Does the father of your child know that you need to take ARVs?  
 
 
6.5 Does he support or help you to take your ARVs?  
 
 
6.6 If yes, how does he support or help you to take your ARVs? 
___________________________________________________________________________
___________________________________________________________________________ 
 
6.7 If the father of your child does not support or help you to take your ARVs, does anyone 
else do this?  
 
 
6.8 If someone else supports or helps you to take your ARVs, what is your relationship with 
that person? Please select all of the people who do this: 
 
 
 
 
 
                                        
                   Other: _________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes  No  
Yes  No  
Yes  No  
Mother  
Father  
Sibling  
Any other family member   
Friend  
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Appendix 4: Qualitative component: Focus group discussion guide: 
 
Broad themes throughout:  
 The nature of women’s relationships with their male partners 
 Gendered power relations within these relationships 
 Gender roles and norms 
 
 
Theme 1: Gender roles 
Broad Questions and Probes: 
 What are the typical roles of men and women? 
o What are their roles when they are in a relationship together? 
o What are their roles and responsibilities when they have a child together? 
 Traditionally, the man is seen as being the one who must earn money 
while the woman stays at home and looks after the house and children 
– is this still true of men and women’s roles today, or have these roles 
changed? 
o Would the fact that a woman is HIV-positive change these roles at all? Does a 
man have different responsibilities when his partner is HIV-positive and 
pregnant? Does a man have any specific responsibilities when his partner is 
accessing PMTCT services?  
 
 
Theme 2: Decision-making regarding having a child 
Broad Questions and Probes: 
 We have noticed that many of the women who we have spoken to had not planned to 
have a child. Do you think that this is true of most women who fall pregnant? 
o If yes, what are the reasons for this? 
 We have also noticed that many unmarried women fall pregnant. Do you think that 
this is the norm nowadays? 
o Is marriage an outdated tradition, or is there still a place for marriage in our 
society? 
 Is it expected for a woman in your community to have a child? 
o If a woman in your community did not have a child, would she be looked down 
on or treated differently? 
 
 
Theme 3: HIV testing and disclosure 
Broad Questions and Probes: 
 Why do you think that HIV testing is important? 
o Is testing only important in an antenatal setting, or are there other important 
situations during which women should be tested? 
 Do women generally tell their partners before they get tested? 
o If not, why do they not tell them? 
 After they have been tested, is it difficult for women to tell their partners their status? 
o If yes, what do you think makes it difficult? If it is not difficult, what do you 
think makes it easy? 
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o Are women given any support from health workers in order to make disclosure 
easier? 
o Is disclosing to a male partner different to disclosing to a family member or 
friend? 
 We would like to speak next about couples counselling and testing, where couples are 
tested and receive counselling together. 
o Is counselling and testing available to couples at this clinic? Are couples 
encouraged to be tested together? 
o Have you ever been offered couples counselling? If yes, where were you 
offered this? 
o Where do you think the best place would be for couples counselling to occur? 
o Do you think that women like you would be willing to have HIV counselling 
and testing with their partners? 
o Would you prefer to be tested on your own, or would you like the opportunity 
to be tested with your partner? 
 
 
Theme 4: Male partner involvement in pregnancy 
Broad Questions and Probes: 
 Do you feel that pregnancy is purely a women’s issue, or is pregnancy something that 
both men and women should be involved in? 
 What do you feel is a man’s role during pregnancy? 
 What are his responsibilities while his female partner is pregnant? Is his only 
responsibility to provide financial support, or is his role more than this? 
o What do your partners do to help you with your pregnancies? 
o What would you like your partners to do to help you with your pregnancies? 
o In your community, what is seen as normal for a man to do to help his female 
partner while she is pregnant? 
o If men are not very involved in pregnancy, then why do you think that they are 
not more involved? Have you experienced barriers against male involvement? 
If yes, what barriers have you experienced? 
 Do you think that men are always supportive of their partners, or do they become 
more supportive and involved when their partners are pregnant? 
o We have noticed that some men support their partners to take their ARVs 
every day. Do you think that male partner support is helpful for adherence? 
Do men become more supportive when their partners are pregnant, or are 
they always supportive (regarding adherence and issues related to HIV)? 
 Do you think that it would be acceptable if a man came with his partner to the clinic 
for antenatal visits? 
o Would other pregnant women find it acceptable? Would the staff at the clinic 
find it acceptable? 
o Is there space in the clinic for men, or do they have to wait outside the clinic? 
o Did your partners come with you to your antenatal visits? Did they come 
inside the clinic, or did they wait outside until you were finished? 
o If men wait outside the clinic, why do you think this happens? What do men do 
while they wait? 
o How would the health care providers treat men if they were present? 
 Do you think that it would be acceptable if a man was present when his partner gave 
birth? 
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o Would other pregnant women find it acceptable? Would the staff at the clinic 
find it acceptable? 
o Is it more acceptable for a man to be present at antenatal visits or when his 
partner gave birth, or are both equally acceptable? 
o Would you like your partner to be present when you give birth? 
o In your community, is it acceptable for a man to be present when his female 
partner gives birth? 
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Appendix 7: AIDS and Behavior: Instructions for authors: 
 
Manuscript Preparation 
 
 Type double-spaced on one side of 8 ½ × 11-inch white paper using generous 
margins on all sides, (including copies of all illustrations and tables). 
 A title page is to be provided and should include the title of the article, authors name 
(no degrees), authors affiliation, and suggested running head. The affiliation should 
comprise the department, institution (usually university or company), city, and state 
(or nation) and should be typed as a footnote to the authors name. The suggested 
running 
head should be less than 80 characters (including spaces) and should comprise the 
article title or an abbreviated version thereof. For office purposes, the title page 
should include the complete mailing address, telephone number, fax number, and 
email address of the one author designated to review proofs. 
 With the exception of Brief Reports and Behavioral Surveillance Reports, initial 
submissions to AIDS and Behavior do not have word or page limits. Briefer and 
more succinct papers tend to review better and papers may be reduced in length as 
part of the review process. However, the length of the original submission is left to 
author discretion. 
 An abstract is to be provided, preferably no longer than 150 words. 
 A list of 4-5 key words is to be provided directly below the abstract. Key words 
should express the precise content of the manuscript, as they are used for indexing 
purposes. 
 All sections should carry headings (such as INTRODUCTION, METHODS, 
RESULTS, DISCUSSION, CONCLUSIONS, etc.), typed flush left. All 
acknowledgments (including those for grant and financial support) should be typed 
in one paragraph (so−headed) on a separate page, that directly precedes the 
References section. 
 Illustrations (photographs, drawings, diagrams, and charts) are to be numbered in 
one consecutive series of Arabic numerals. The captions for illustrations should be 
typed on a separate sheet of paper. All illustrations must be complete and final, i.e., 
camera-ready. Photographs should be large, glossy prints, showing high contrast. 
Drawings should be high quality laser prints or should be prepared with india ink. 
Either the original drawings or good−quality photographic prints are acceptable. 
Artwork for each figure should be provided on a separate sheet of paper. Identify 
figures on the back with authors name and number of the illustration. Electronic 
artwork submitted on disk should be in the TIFF or EPS format (1200 dpi for line 
and 300 dpi for halftones and grayscale art). Color art should be in the CYMK color 
space. Artwork should be on a separate disk from the text, and hard copy must 
accompany the disk. 
 Tables should be numbered (with Roman numerals) and referred to by number in 
the text. Each table should be typed on a separate sheet of paper. Center the title 
above the table, and type explanatory footnotes (indicated by superscript lowercase 
letters) below the table. 
 AIDS and Behavior does not have a limit on number of authors. However, if 
deemed to be excessive the editor may request author justifications and reductions. 
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Manual of style: A Guide for Authors and Editors, 10th Edition. 
A reference number is allocated to a source in the order in which it is cited in the text. In text, 
identify references as Arabic numerals in brackets (1). If the source is referred to again, the 
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Verify that every instance of a number in text corresponds to the numbered reference. 
Footnotes should be avoided. When their use is absolutely necessary, footnotes should be 
numbered consecutively using Arabic numerals and should be typed at the bottom of the page 
to which they refer. Place a line above the footnote, so that it is set off from the text. Use the 
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